
From Scientific Innovation to Commercial Success ACI’s Biostimulants Europe 2027 will take place on 27th–28th January 2027 in Barcelona, Spain, bringing together senior representatives from across the European biostimulants industry to explore the scientific, commercial and regulatory developments shaping the future of biological crop inputs. As growers face increasing pressure to improve productivity, reduce dependence on conventional fertilisers and adapt to changing environmental conditions, biostimulants are becoming an increasingly important part of modern crop production. The conference brings together biostimulant manufacturers, fertiliser companies, growers, agronomists, distributors, researchers, technology providers and regulatory specialists to examine how biological innovation is being translated into practical, profitable farming solutions. The programme focuses on the practical realities influencing the successful adoption of biostimulants across European agriculture. Discussions will explore how manufacturers are demonstrating measurable return on investment, improving farm profitability and integrating biological products into modern crop management programmes. Sessions will also examine advances in microbial technologies, soil health, climate resilience, artificial intelligence and predictive agronomy, highlighting how scientific innovation is accelerating product development and supporting more sustainable, resilient farming systems. Alongside these themes, the conference examines the evolving regulatory and commercial landscape shaping the European biostimulants market. Delegates will gain insight into developments under the EU Fertilising Products Regulation, approaches to demonstrating efficacy and substantiating product claims, and the factors influencing product registration and market access. Across two days of presentations, panel discussions and networking in Barcelona, Biostimulants Europe 2027 provides a valuable forum for industry leaders to exchange knowledge, explore emerging opportunities and discuss the innovations driving the continued growth of the European biostimulants sector.